does harvard pilgrim cover semaglutide Health Care Why Blue Cross Blue Shield

However, current evidence is still inconclusive to demonstrate a direct negative effect of GLP-1 RAs on LBM loss, largely due to heterogeneity in study designs and the limited number of trials specifically evaluating this endpoint [77]

The evidence base does not extend to a confident statement that cycled use is safe long-term it simply is not studied

They reported mild gastrointestinal symptoms and no substantial changes in disease activity scores (104, 105)

Scientists now recognize that aging reflects a set of measurable biological processes that influence how cells respond to stress, repair damage, and maintain normal function

This is not a job for a weight-loss clinic alone